Mirae Asset Global Investments
CTKB icon

Mirae Asset Global Investments’s Cytek Biosciences CTKB Stock Holding History

Mirae Asset Global Investments’s Portfolio CTKB Stock Details CTKB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-49,053
Closed -$421K – 1758
2024
Q1 		$421K Hold
49,053
– – ﹤0.01% 1978
2023
Q4 		$447K Hold
49,053
– – ﹤0.01% 2017
2023
Q3 		$271K Hold
49,053
– – ﹤0.01% 2175
2023
Q2 		$419K Hold
49,053
– – ﹤0.01% 2021
2023
Q1 		$451K Hold
49,053
– – ﹤0.01% 1979
2022
Q4 		$501K Buy
49,053
+1,473
+3% +$19.8K ﹤0.01% 1893
2022
Q3 		$700K Buy
47,580
+14,620
+44% +$190K ﹤0.01% 1684
2022
Q2 		$354K Buy
+32,960
New +$328K ﹤0.01% 1907

Other funds holding CTKB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Mirae Asset Global Investments's CTKB Position: Q2 2024 in Review

Mirae Asset Global Investments sold out of Cytek Biosciences (CTKB) in Q2 2024, closing a stake of 49,053 shares — an estimated $421K sold.

Mirae Asset Global Investments first reported a position in CTKB in Q2 2022 and held it in 8 quarters. The position peaked at $700K in Q3 2022. 128 funds tracked by Wall St. Rank hold CTKB as of Q2 2024.

  • Mirae Asset Global Investments reported no remaining Cytek Biosciences position as of Q2 2024 after selling out during the quarter.
  • Mirae Asset Global Investments sold 49,053 Cytek Biosciences shares in Q2 2024, an estimated $421K.
  • Mirae Asset Global Investments first reported a position in Cytek Biosciences in Q2 2022 and held it in 8 quarters.
  • Mirae Asset Global Investments's Cytek Biosciences position peaked at $700K in Q3 2022.
  • 128 funds tracked by Wall St. Rank held Cytek Biosciences as of Q2 2024.

Based on Mirae Asset Global Investments's 13F filing for Q2 2024, filed 30 Jul 2024.